Sosmena, Mary Jane .
HRN: 27-44-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
METRONIDAZOLE 500MG (TAB)
07/10/2025
07/17/2025
PO
500mg
TID
S/P NSVD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes